Sorrento Therapeutics, Inc. Contracts & Agreements

Asset Purchase Agreement, dated October 30, 2023, between Yuhan Corporation and Sorrento Therapeutics, Inc (Filed With SEC on November 3, 2023)

Manufacturing Technology Transfer Agreement, dated November 2, 2023, between Yuhan Corporation and Sorrento Therapeutics, Inc (Filed With SEC on November 3, 2023)

Stock Purchase Agreement, dated September 29, 2023, between Dr. Robert J. Hariri, M.D., Ph. D., and Sorrento Therapeutics, Inc (Filed With SEC on October 5, 2023)

Stock Purchase Agreement, dated September 21, 2023, between Scilex Holding Company and Sorrento Therapeutics, Inc (Filed With SEC on September 26, 2023)

Mutual Termination and Release Agreement, dated September 21, 2023, between Sorrento Therapeutics, Inc. and Oramed Pharmaceuticals, Inc (Filed With SEC on September 26, 2023)

Assignment, Assumption and Release Agreement, dated September 21, 2023, between Scilex Holding Company, Oramed Pharmaceuticals, Inc., Sorrento Therapeutics, Inc. and Scintilla... (Filed With SEC on September 26, 2023)

Second Amendment to Stock Purchase Agreement, dated August 21, 2023, between Sorrento Therapeutics, Inc. amd Oramed Pharmaceuticals Inc (Filed With SEC on August 28, 2023)

Stock Purchase Agreement, Dated August 7, 2023 between Sorrento Therapeutics, Inc. and Oramed Pharmaceuticals Inc (Filed With SEC on August 10, 2023)

Amendment Agreement to Stock Purchase Agreement, Dated August 9, 2023, between Sorrento Therapeutics, Inc. amd Oramed Pharmaceutircals Inc (Filed With SEC on August 10, 2023)

Senior Secured, Super-Priority Debtor-In-Possession Loan and Security Agreement, dated March 30, 2023, by and among Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc.,... (Filed With SEC on August 10, 2023)

Debtor-in-Possession Term Loan Facility Summary of Terms and Conditions, dated as of July 5, 2023, between Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc. and Scilex... (Filed With SEC on July 10, 2023)

Intercreditor and Subordination Agreement, dated as of July 5, 2023, by and among JMB Capital Partners Lending, LLC and Scilex Holding Company (Filed With SEC on July 10, 2023)

Senior Secured, Super-Priority Debtor-In-Possession Loan and Security Agreement, dated March 30, 2023, by and among Sorrento Therapeutics, Inc., Scintilla Pharmaceuticals, Inc.,... (Filed With SEC on March 31, 2023)

Sorrento Therapeutics, Inc. 2019 Stock Incentive Plan, as amended (Filed With SEC on December 16, 2022)

Bridge Loan Agreement, dated as of September 30, 2022, by and between Sorrento Therapeutics, Inc. and B. Riley Commercial Capital, LLC (Filed With SEC on November 8, 2022)

Amendment No. 1 to Agreement and Plan of Merger, dated as of September 12, 2022, by and among Vickers Vantage Corp. I, Vantage Merger Sub Inc. and Scilex Holding Company (Filed With SEC on September 14, 2022)

Contribution and Satisfaction of Indebtedness Agreement, dated as of September 12, 2022, by and among Sorrento Therapeutics, Inc., Scilex Holding Company and Scilex... (Filed With SEC on September 14, 2022)

Stockholder Agreement, dated as of September 12, 2022, by and among Sorrento Therapeutics, Inc. and Vickers Vantage Corp. I (Filed With SEC on September 14, 2022)

Amendment No. 1 to Sponsor Support Agreement, dated as of September 12, 2022, by and among Vickers Vantage Corp. I, Scilex Holding Company and each of the Persons set forth on... (Filed With SEC on September 14, 2022)

Consent Under and Amendment No. 4 to Indenture, dated June 3, 2022, by and among Sorrento Therapeutics, Inc., Scilex Pharmaceuticals Inc., U.S. Bank Trust Company, National... (Filed With SEC on June 3, 2022)

Offer Letter, dated April 27, 2022, between Sorrento Therapeutics, Inc. and Elizabeth A. Czerepak (Filed With SEC on April 28, 2022)

Offer Letter, dated April 27, 2022, between Scilex Holding Company and Elizabeth A. Czerepak (Filed With SEC on April 28, 2022)

Agreement and Plan of Merger, dated as of March 17, 2022, by and among Vickers Vantage Corp. I, Vantage Merger Sub Inc. and Scilex Holding Company (Filed With SEC on March 18, 2022)

Sponsor Support Agreement, dated as of March 17, 2022, by and among Vickers Vantage Corp. I and each of the Persons set forth on Schedule I attached thereto (Filed With SEC on March 18, 2022)

Company Stockholder Support Agreement, dated as of March 17, 2022, by and among Sorrento Therapeutics, Inc., Scilex Holding Company and Vickers Vantage Corp. I (Filed With SEC on March 18, 2022)

Form of Amended and Restated Registration Rights Agreement (Filed With SEC on March 18, 2022)

Description of Securities of Sorrento Therapeutics, Inc (Filed With SEC on March 11, 2022)

Agreement and Plan of Merger, dated January 14, 2022, by and among Sorrento Therapeutics, Inc., VH Merger Sub I, Inc., VH Merger Sub II, LLC, Virex Health, Inc. and Fortis... (Filed With SEC on January 19, 2022)

Amendment No. 1 to Amended and Restated Sales Agreement, dated as of December 23, 2021, by and among Sorrento Therapeutics, Inc., Cantor Fitzgerald & Co., B. Riley Securities,... (Filed With SEC on December 23, 2021)

Amended and Restated Sales Agreement, dated as of December 3, 2021, by and among Sorrento Therapeutics, Inc., Cantor Fitzgerald & Co., B. Riley Securities, Inc., H.C. Wainwright &... (Filed With SEC on December 3, 2021)

Earn-Out Agreement, dated June 1, 2021, by and between Sorrento Therapeutics, Inc. and Fortis Advisors LLC (Filed With SEC on June 4, 2021)

Contract, dated August 15, 2018, by and between Hangzhou ACEA Pharmaceutical Research Co., Ltd. and ACEA Bio (Hangzhou) Co., Ltd. (translated into English from its original text... (Filed With SEC on June 4, 2021)

Loan Agreement, dated January 6, 2018, by and between Zhejiang ACEA Pharmaceutical Co., Ltd. and ACEA Bio (Hangzhou) Co., Ltd. (translated into English from its original text in... (Filed With SEC on June 4, 2021)

Binding Term Sheet, dated as of February 24, 2021, by and between Sorrento Therapeutics, Inc. and ANP Technologies, Inc (Filed With SEC on May 5, 2021)

Exclusive License Agreement, dated as of March 4, 2021, by and between Sorrento Therapeutics, Inc. and the Icahn School of Medicine at Mount Sinai (Filed With SEC on May 5, 2021)

Amendment to Binding Term Sheet, dated as of April 20, 2021, by and between Sorrento Therapeutics, Inc. and ANP Technologies, Inc (Filed With SEC on May 5, 2021)

Sorrento Therapeutics, Inc. 2021 Cash-Settled Stock Appreciation Rights Plan (Filed With SEC on May 5, 2021)

Sorrento Therapeutics, Inc. Stock Appreciation Rights Award Agreement (Filed With SEC on May 5, 2021)

Agreement and Plan of Merger, dated April 2, 2021, by and among Sorrento Therapeutics, Inc., AT Merger Sub, Inc., ACEA Therapeutics, Inc. and Fortis Advisors LLC, as... (Filed With SEC on April 5, 2021)

Description of Securities of Sorrento Therapeutics, Inc (Filed With SEC on February 19, 2021)

License Agreement, dated as of October 12, 2020, by and between Sorrento Therapeutics, Inc. and Personalized Stem Cells (Filed With SEC on February 19, 2021)

Binding Term Sheet, dated as of October 14, 2020, by and between Sorrento Therapeutics, Inc. and ACEA Therapeutics, Inc (Filed With SEC on February 19, 2021)

Consent Under and Amendment No. 3 to Indenture and Letter of Credit, dated December 14, 2020, by and among Scilex Pharmaceuticals Inc., Sorrento Therapeutics, Inc., U.S. Bank... (Filed With SEC on December 15, 2020)

Amendment No. 1 to Sales Agreement, dated as of December 4, 2020, by and between Sorrento Therapeutics, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on December 4, 2020)

License Agreement, dated as of July 13, 2020, by and between Sorrento Therapeutics, Inc. and ACEA Therapeutics, Inc (Filed With SEC on November 9, 2020)

Exclusive License Agreement, dated as of July 23, 2020, by and between Sorrento Therapeutics, Inc. and The Trustees of Columbia University in the City of New York (Filed With SEC on November 9, 2020)

Patent and Know-How License Agreement, dated as of September 8, 2020, by and between Sorrento Therapeutics, Inc. and Mayo Foundation for Medical Education and Research (Filed With SEC on November 9, 2020)

Change of Control Severance Agreement, dated as of November 5, 2020, by and between Sorrento Therapeutics, Inc. and Najjam Ashgar (Filed With SEC on November 9, 2020)

Sorrento Therapeutics, Inc. 2020 Employee Stock Purchase Plan (Filed With SEC on October 20, 2020)

Sorrento Therapeutics, Inc. 2019 Stock Incentive Plan (Filed With SEC on October 20, 2020)

Performance Stock Option Award Agreement, dated as of August 7, 2020, by and between Sorrento Therapeutics, Inc. and Henry Ji, Ph.D (Filed With SEC on October 20, 2020)

First Amendment to Exchange and Registration Rights Agreement, dated September 28, 2020, by and between Sorrento Therapeutics, Inc. and Fortis Advisors LLC in its capacity as the... (Filed With SEC on October 2, 2020)

Agreement and Plan of Merger, dated August 20, 2020, by and among Sorrento Therapeutics, Inc., SP Merger Sub, Inc., SmartPharm Therapeutics, Inc. and John C. Thomas, Jr., as... (Filed With SEC on August 20, 2020)

Outside Director Compensation Policy (Filed With SEC on August 4, 2020)

Omnibus Amendment No. 2 to Indenture and Letter of Credit, dated as of March 30, 2020, by and among Scilex Pharmaceuticals, Inc., Sorrento Therapeutics, Inc., U.S. Bank National... (Filed With SEC on May 11, 2020)

Binding Term Sheet, dated as of March 31, 2020, by and between Sorrento Therapeutics, Inc., and Nanjing Hongjing Enterprise Management Consulting Co., Ltd (Filed With SEC on May 11, 2020)

Sales Agreement, dated as of April 27, 2020, by and between Sorrento Therapeutics, Inc. and A.G.P/Alliance Global Partners (Filed With SEC on April 27, 2020)

Common Stock Purchase Agreement, dated as of April 27, 2020, by and between Sorrento Therapeutics, Inc. and Arnaki Ltd (Filed With SEC on April 27, 2020)

Description of Securities of Sorrento Therapeutics, Inc (Filed With SEC on March 3, 2020)

Registration Rights Agreement, dated as of February 10, 2020, by and between Sorrento Therapeutics, Inc. and Aspire Capital Fund, LLC (Filed With SEC on February 11, 2020)

Common Stock Purchase Agreement, dated as of February 10, 2020, by and between Sorrento Therapeutics, Inc. and Aspire Capital Fund, LLC (Filed With SEC on February 11, 2020)

Form of Warrant, dated December 6, 2019, issued by Sorrento Therapeutics, Inc (Filed With SEC on December 9, 2019)

Amendment No. 2 to the Registration Rights Agreement, dated as of December 6, 2019, by and among Sorrento Therapeutics, Inc. and the persons party thereto (Filed With SEC on December 9, 2019)

Amendment No. 1 to Agreement and Plan of Merger, dated as of August 7, 2019, by and between Scilex Holding Company and Fortis Advisors LLC, solely as the Equityholders... (Filed With SEC on November 12, 2019)

Note Conversion Agreement, dated as of November 8, 2019, by and among Sorrento Therapeutics, Inc. and the holders of convertible notes issued by Sorrento Therapeutics, Inc. as is... (Filed With SEC on November 12, 2019)

Form of Securities Purchase Agreement, dated October 7, 2019, by and between the Company and the purchasers party thereto (Filed With SEC on October 8, 2019)

Equity Distribution Agreement, dated as of October 1, 2019, by and between Sorrento Therapeutics, Inc. and JMP Securities LLC (Filed With SEC on October 1, 2019)

Omnibus Amendment No. 1 to Indenture and Letter of Credit, dated as of October 1, 2019, by and among Scilex Pharmaceuticals Inc., Sorrento Therapeutics, Inc., U.S. Bank National... (Filed With SEC on October 1, 2019)

Sorrento Therapeutics, Inc. 2019 Stock Incentive Plan (Filed With SEC on September 23, 2019)

Underwriting Agreement, dated as of June 28, 2019, by and between Sorrento Therapeutics, Inc. and JMP Securities LLC, as representative of the underwriters named therein (Filed With SEC on June 28, 2019)

Form of Series A Warrant (Filed With SEC on June 28, 2019)

Form of Series B Warrant (Filed With SEC on June 28, 2019)

Form of Series C Warrant (Filed With SEC on June 28, 2019)

Form of Warrant, dated May 3, 2019, issued by Sorrento Therapeutics, Inc (Filed With SEC on May 3, 2019)

Amendment No. 1 to the Registration Rights Agreement, dated as of May 3, 2019, by and among Sorrento Therapeutics, Inc. and the persons party thereto (Filed With SEC on May 3, 2019)

Amendment No. 1 to Term Loan Agreement, dated as of May 3, 2019, by and among Sorrento Therapeutics, Inc., certain subsidiaries of Sorrento Therapeutics, Inc., as guarantors,... (Filed With SEC on May 3, 2019)

Exchange and Registration Rights Agreement, dated as of March 18, 2019, by and among Sorrento Therapeutics, Inc. and the stockholders and stock option holders of Semnur... (Filed With SEC on March 22, 2019)

Agreement and Plan of Merger, dated as of March 18, 2019, by and among Sorrento Therapeutics, Inc., Semnur Pharmaceuticals, Inc., Scilex Holding Company, Sigma Merger Sub, Inc.... (Filed With SEC on March 22, 2019)

First Amendment to Office Lease, dated October 19, 2018, between Sorrento Therapeutics, Inc. and HCP Life Science REIT, Inc (Filed With SEC on March 15, 2019)

Lease Agreement, dated November 13, 2018, between Sorrento Therapeutics, Inc. and HCP Life Science Estates, Inc (Filed With SEC on March 15, 2019)

Form of Warrant, dated November 7, 2018, issued by Sorrento Therapeutics, Inc (Filed With SEC on November 9, 2018)

Registration Rights Agreement, dated November 7, 2018, by and among Sorrento Therapeutics, Inc. and the parties identified on Schedule A thereto (Filed With SEC on November 9, 2018)

Indenture and form of Note issued thereunder, dated as of September 7, 2018, by and among Scilex Pharmaceuticals Inc., as issuer, Sorrento Therapeutics, Inc., as parent guarantor,... (Filed With SEC on November 9, 2018)

Form of Purchase Agreement, dated as of September 7, 2018, by and among Scilex Pharmaceuticals Inc., Sorrento Therapeutics, Inc. and the purchasers party thereto (Filed With SEC on November 9, 2018)

Collateral Agreement, dated as of September 7, 2018, by and between Scilex Pharmaceuticals Inc. and U.S. Bank National Association, as trustee and collateral agent (Filed With SEC on November 9, 2018)

Irrevocable Standby Letter of Credit, dated September 7, 2018, issued by Sorrento Therapeutics, Inc (Filed With SEC on November 9, 2018)

Term Loan Agreement, dated November 7, 2018, by and among Sorrento Therapeutics, Inc., certain subsidiaries of Sorrento Therapeutics, Inc., the lenders party thereto and Oaktree... (Filed With SEC on November 9, 2018)

Agreement and Consent, dated November 7, 2018, by and among Sorrento Therapeutics, Inc. and the Warrant Holders party thereto (Filed With SEC on November 9, 2018)

Amended and Restated 2009 Stock Incentive Plan, as amended (Filed With SEC on August 28, 2018)

Form of Convertible Promissory Note issued to investors pursuant to the Securities Purchase Agreement, dated as of June 13, 2018, by and among Sorrento Therapeutics, Inc. and the... (Filed With SEC on June 14, 2018)

Form of Common Stock Purchase Warrant issued to investors pursuant to the Securities Purchase Agreement, dated as of June 13, 2018, by and among Sorrento Therapeutics, Inc. and... (Filed With SEC on June 14, 2018)

Registration Rights Agreement, dated June 13, 2018, by and among Sorrento Therapeutics, Inc. and the purchasers identified on Schedule A thereto (Filed With SEC on June 14, 2018)

Amendment No. 1 to Securities Purchase Agreement, effective June 13, 2018, by and among Sorrento Therapeutics, Inc. and the purchasers set forth on the signature pages thereto (Filed With SEC on June 14, 2018)

Offer Letter, dated March 15, 2018, by and between Sorrento Therapeutics, Inc. and Jiong Shao (Filed With SEC on May 10, 2018)

Securities Purchase Agreement, dated as of March 26, 2018, by and among Sorrento Therapeutics, Inc. and the purchasers identified on Schedule A thereto (Filed With SEC on May 10, 2018)

Amendment No. 1 to Share Purchase Agreement, effective April 27, 2018, by and among Sorrento Therapeutics, Inc., TNK Therapeutics, Inc. and Dayspring Ventures Limited, as... (Filed With SEC on April 27, 2018)

Form of Convertible Promissory Note issued to investors pursuant to the Securities Purchase Agreement, dated as of December 11, 2017, by and among Sorrento Therapeutics, Inc. and... (Filed With SEC on December 21, 2017)

Form of Common Stock Purchase Warrant issued to investors pursuant to the Securities Purchase Agreement, dated as of December 11, 2017, by and among Sorrento Therapeutics, Inc.... (Filed With SEC on December 21, 2017)

Registration Rights Agreement, dated December 21, 2017, by and among Sorrento Therapeutics, Inc. and the purchasers identified on Schedule A thereto (Filed With SEC on December 21, 2017)

Securities Purchase Agreement, dated as of December 11, 2017, by and among Sorrento Therapeutics, Inc. and the purchasers identified on Schedule A thereto (Filed With SEC on December 11, 2017)

License and Transfer Agreement dated August 15, 2017 by and among Sorrento Therapeutics, Inc., TNK Therapeutics, Inc. and Celularity, Inc (Filed With SEC on November 9, 2017)

Amendment No. 2 to Contribution Agreement, dated as of August 10, 2017, by and among Sorrento Therapeutics, Inc., TNK Therapeutics, Inc. and Celularity, Inc (Filed With SEC on November 9, 2017)

Seventh Amendment to Loan and Security Agreement, dated November 6, 2017, among Sorrento Therapeutics, Inc., certain of its domestic subsidiaries, and Hercules Capital, Inc (Filed With SEC on November 9, 2017)

FIFTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 9, 2017)

CONSENT AND SIXTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on August 9, 2017)

CONTRIBUTION AGREEMENT by and among CELULARITY, INC., TNK THERAPEUTICS, INC. and SORRENTO THERAPEUTICS, INC. Dated: June 12, 2017 (Filed With SEC on August 9, 2017)

AMENDMENT NO. 1 TO PROMISSORY NOTE (Filed With SEC on August 9, 2017)

AMENDMENT NO. 1 TO CONTRIBUTION AGREEMENT (Filed With SEC on August 9, 2017)

AMENDMENT NO. 2 TO PROMISSORY NOTE (Filed With SEC on August 9, 2017)

Fourth Amendment to Loan and Security Agreement, dated March 23, 2017, among Sorrento Therapeutics, Inc., certain of its domestic subsidiaries, and Hercules Capital, Inc (Filed With SEC on May 15, 2017)

Amendment No. 3 to Stock Purchase Agreement, dated as of March 14, 2017, by and between TNK Therapeutics, Inc. and Richard P. Junghans, M.D., Ph.D., as the Stockholders... (Filed With SEC on May 15, 2017)

Amended and Restated Employment Agreement between Sorrento Therapeutics, Inc. and Henry Ji, Ph.D. dated May 9, 2017 (Filed With SEC on May 15, 2017)

SHARE PURCHASE AGREEMENT by and among TNKTherapeutics, Inc., VirttuBiologics Limited, TheShareholders of Virttu Biologics Limited, DayspringVentures Limited, as the... (Filed With SEC on April 28, 2017)

SORRENTO THERAPEUTICS, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on April 28, 2017)

23,625,084 Shares SORRENTO THERAPEUTICS,INC. UNDERWRITING AGREEMENT(this “Agreement”) (Filed With SEC on April 13, 2017)

PROMISSORY NOTE (Filed With SEC on March 22, 2017)

BINDING TERM SHEET FOR VIRTTU BIOLOGICS ACQUISITION (Filed With SEC on March 22, 2017)

LOAN AND SECURITY AGREEMENT (Filed With SEC on March 22, 2017)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 22, 2017)

Amendment No. 2 to Stock PURCHASE AGREEMENT (Filed With SEC on March 22, 2017)

SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 22, 2017)

THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 22, 2017)

WARRANT AGREEMENT To PurchaseShares of the Common Stock of SORRENTO THERAPEUTICS, INC. Dated as of November 23, 2016 (the Effective Date) (Filed With SEC on November 29, 2016)

BINDING TERM SHEET FOR sCILEX PHARMACEUTICALS, INc. ACQUISITION AUGUST 2, 2016 (Filed With SEC on November 9, 2016)

BINDING TERM SHEET August 15, 2016 (Filed With SEC on November 9, 2016)

SORRENTO GATEWAY LEASE (Filed With SEC on November 9, 2016)

Amendment No. 1 to MEmbership Interest PURCHASE AGREEMENT (Filed With SEC on November 9, 2016)

AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT (Filed With SEC on November 9, 2016)

STOCK PURCHASE AGREEMENT by and among SORRENTO THERAPEUTICS, INC., SCILEX PHARMACEUTICALS INC., THE STOCKHOLDERS OF SCILEX PHARMACEUTICALS INC., AND SPISHAREHOLDERS... (Filed With SEC on November 8, 2016)

SORRENTO THERAPEUTICS, INC. REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 8, 2016)

[Signature Page Follows] (Filed With SEC on August 8, 2016)

LICENSE AND COLLABORATION AGREEMENT BETWEEN LES LABORATOIRES SERVIER INSTITUT DE RECHERCHES INTERNATIONALES SERVIER AND SORRENTO THERAPEUTICS, INC. (Filed With SEC on August 8, 2016)

SORRENTO THERAPEUTICS, INC. Employment Agreement (Filed With SEC on May 10, 2016)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 15, 2016)

OPTION AGREEMENT (Filed With SEC on March 15, 2016)

SORRENTO THERAPEUTICS, INC. and PHILADELPHIA STOCK TRANSFER, INC., Rights Agent Amended and Restated Rights Agreement Dated asof December 21, 2015 TABLE OF CONTENTS (Filed With SEC on December 21, 2015)

MEMBERSHIP INTEREST PURCHASE AGREEMENT by and among TNK Therapeutics, Inc., CARgenix Holdings LLC The Members of CARgenix Holdings LLC, Jaymin Patel, as the Members Representative... (Filed With SEC on November 16, 2015)

STOCK PURCHASE AGREEMENT by and among TNK Therapeutics, Inc., BDL Products, Inc. The Stockholders of BDL Products, Inc., Richard Junghans, M.D., PH.D., as the Stockholders... (Filed With SEC on November 16, 2015)

BINDING TERM SHEET FOR LICENSE BETWEEN CYTOLUMINA/FETOLUMINA AND TNK THERAPEUTICS (Filed With SEC on November 16, 2015)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on November 16, 2015)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on August 7, 2015)

STOCK SALE AND PURCHASE AGREEMENT (Filed With SEC on August 7, 2015)

COMMON STOCK PURCHASE WARRANT SORRENTO THERAPEUTICS, INC. (Filed With SEC on March 16, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 16, 2015)

FIRST AMENDMENT TO SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 16, 2015)

LEASE UNIVERSITY CENTER WEST HCP UNIVERSITY CENTER WEST LLC, a Delaware limited liability company, as Landlord, and SORRENTO THERAPEUTICS, INC., a Delaware corporation, as Tenant.... (Filed With SEC on March 16, 2015)

FIRSTAMENDMENT TO SUBSCRIPTION AND INVESTMENT AGREEMENT (Filed With SEC on December 29, 2014)

STOCKHOLDERS AGREEMENT dated as of December23, 2014 by and among CONKWEST, INC., SORRENTO THERAPEUTICS, INC., CAMBRIDGE EQUITIES, LP and THE PERSONS LISTEDON SCHEDULE A HERETO... (Filed With SEC on December 29, 2014)

SORRENTO THERAPEUTICS, INC. and PHILADELPHIA STOCK TRANSFER, INC., Rights Agent Amended and Restated Rights Agreement Dated asof December 22, 2014 1 TABLE OF CONTENTS (Filed With SEC on December 23, 2014)

SUBSCRIPTION AND INVESTMENT AGREEMENT (Filed With SEC on December 19, 2014)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 19, 2014)

Exclusive License and Development Agreement between Sorrento Therapeutics, Inc. and China Oncology Focus Limited 1 (Filed With SEC on November 4, 2014)

CONSENT AND SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on November 4, 2014)

AMENDMENT #7 (Filed With SEC on August 6, 2014)

UNDERWRITING AGREEMENT between SORRENTOTHERAPEUTICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters SORRENTO THERAPEUTICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on May 15, 2014)

AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on April 1, 2014)

SORRENTO THERAPEUTICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on April 1, 2014)

AGREEMENT OF MERGER by and among: SORRENTO THERAPEUTICS, INC., a Delaware corporation; CATALYST MERGER SUB, INC., a Delaware corporation; CONCORTIS BIOSYSTEMS, CORP., a Delaware... (Filed With SEC on November 14, 2013)

SORRENTO THERAPEUTICS, INC. and COMPUTERSHARE TRUST COMPANY, N.A., Rights Agent Rights Agreement Dated as of November 7, 2013 TABLE OF CONTENTS (Filed With SEC on November 12, 2013)

UNDERWRITING AGREEMENT between SORRENTOTHERAPEUTICS, INC. and AEGIS CAPITAL CORP., as Representative of the Several Underwriters SORRENTO THERAPEUTICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on October 25, 2013)

CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 21, 2013)

AGREEMENT AND PLAN OF MERGER AND REORGANIZATION among: SORRENTO THERAPEUTICS, INC., a Delaware corporation; SPMERGER SUB, INC., a Delaware corporation; SHERRINGTON... (Filed With SEC on October 15, 2013)

LOAN AND SECURITY AGREEMENT (Filed With SEC on October 15, 2013)

REGISTRATION RIGHTSAGREEMENT BY AND AMONG SORRENTO THERAPEUTICS, INC. AND THE STOCKHOLDERS OF SHERRINGTON PHARMACEUTICALS,INC. Dated as of October 9, 2013 1 REGISTRATION RIGHTS... (Filed With SEC on October 15, 2013)

AGREEMENT OF MERGER among: SORRENTO THERAPEUTICS, INC., a Delaware corporation; STIMERGER SUB, INC., a Delaware corporation; IGDRASOL, INC., a Delaware corporation;... (Filed With SEC on September 11, 2013)

EXCLUSIVE OPTION AGREEMENT by and between B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., an Israeli Company and SORRENTO THERAPEUTICS, INC., a Delaware (US) corporation EXCLUSIVE... (Filed With SEC on August 13, 2013)

OPTION AGREEMENT Dated as of March 7, 2013 by and between SORRENTO THERAPEUTICS, INC. and IGDRASOL, INC. TABLE CONTENTS (Filed With SEC on May 15, 2013)

ASSIGNMENT AGREEMENT by and between TIEN-LI LEE, M.D. AND JANE WU LEE, M.D., as individuals and SORRENTO THERAPEUTICS, INC., a Delaware (U.S.) corporation ASSIGNMENT AGREEMENT (Filed With SEC on May 15, 2013)

ASSET PURCHASE AGREEMENT (Filed With SEC on May 15, 2013)

SERVICES AGREEMENT (Filed With SEC on May 15, 2013)

VOTING AGREEMENT (Filed With SEC on May 15, 2013)

SORRENTO THERAPEUTICS, INC. INDEPENDENT DIRECTOR COMPENSATION POLICY (as amended through December 12, 2012) (Filed With SEC on March 25, 2013)

STOCK OPTION CANCELLATION AGREEMENT AND OPTION AMENDMENT (Filed With SEC on March 25, 2013)

STOCK OPTION CANCELLATION AGREEMENT (Filed With SEC on March 25, 2013)

STOCK PURCHASE AGREEMENT (Filed With SEC on March 14, 2013)

LOAN AND SECURITY AGREEMENT (Filed With SEC on February 26, 2013)

SORRENTO THERAPEUTICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on November 8, 2012)

FIRST AMENDMENT TO EMPLOYMENT AGREEMENT (Filed With SEC on November 8, 2012)

INDEMNIFICATION AGREEMENT (Filed With SEC on September 7, 2012)

AMENDMENT #6 (Filed With SEC on August 14, 2012)

FIRST AMENDMENT TO STOCK PURCHASE AGREEMENT (Filed With SEC on May 15, 2012)

SECOND AMENDMENT TO STOCK PURCHASE AGREEMENT (Filed With SEC on May 15, 2012)

AMENDED AND RESTATED STOCK PURCHASE AGREEMENT (Filed With SEC on May 14, 2012)

AMENDMENT #3 (Filed With SEC on March 30, 2012)

AMENDMENT #4 (Filed With SEC on March 30, 2012)

AMENDMENT #5 (Filed With SEC on March 30, 2012)

STOCK PURCHASE AGREEMENT (Filed With SEC on January 5, 2012)

CONSULTING AGREEMENT (Filed With SEC on April 27, 2011)

AMENDMENT #3 (Filed With SEC on March 18, 2011)

AMENDMENT #4 (Filed With SEC on March 18, 2011)

STOCK PURCHASE AGREEMENT (Filed With SEC on December 23, 2010)

LICENSE AGREEMENT by and between THE SCRIPPS RESEARCH INSTITUTE, a California nonprofit public benefit corporation and SORRENTO THERAPEUTICS, INC., a Delaware corporation (Filed With SEC on May 14, 2010)

CONSULTING AGREEMENT (Filed With SEC on March 25, 2010)

SORRENTO THERAPEUTICS, INC. 6042 CORNERSTONE CT.WEST, SUITE B SAN DIEGO, CA 92121, USA (Filed With SEC on March 25, 2010)

AMENDMENT #2 (Filed With SEC on March 25, 2010)

SORRENTO THERAPEUTICS, INC. 2009 EQUITY INCENTIVEPLAN Approved by the Board of Directors: February 5, 2009 (Filed With SEC on March 25, 2010)

AMENDMENT #2 (Filed With SEC on November 12, 2009)

PLAN OF CONVERSION OF QuikByte Software, Inc., aColorado corporation, INTO QuikByte Software, Inc., a Delaware corporation (Filed With SEC on October 23, 2009)

SORRENTO THERAPEUTICS, INC. TRANSFER FEE $25.00 (Filed With SEC on October 23, 2009)

SORRENTO THERAPEUTICS, INC. INDEMNITY AGREEMENT (Filed With SEC on October 23, 2009)

SORRENTO THERAPEUTICS, INC. 2009 STOCK INCENTIVEPLAN (Filed With SEC on October 23, 2009)

ESCROW AGREEMENT (Filed With SEC on September 22, 2009)

NONQUALIFIED STOCK OPTION AGREEMENT FOR QUIKBYTE SOFTWARE, INC. Agreement (Filed With SEC on September 22, 2009)

STOCK PURCHASE AGREEMENT (Filed With SEC on September 21, 2009)

LOCK-UP AGREEMENT (Filed With SEC on September 21, 2009)

ESCROW AGREEMENT (Filed With SEC on September 21, 2009)

QuikByte Software, Inc. 4400 Biscayne Boulevard, Suite 950 Miami, Florida 33137 (Filed With SEC on September 21, 2009)

STANDARD MULTI-TENANTOFFICE LEASE - NET (Filed With SEC on September 21, 2009)

FIRSTAMENDMENT TO LEASE (Filed With SEC on September 21, 2009)

STOCK PURCHASE AGREEMENT (Filed With SEC on September 21, 2009)

LIMITED LICENSE AGREEMENT (Filed With SEC on September 21, 2009)

PATENT ASSIGNMENT AGREEMENT (Filed With SEC on September 21, 2009)

NONQUALIFIED STOCK OPTION AGREEMENT FOR QUIKBYTE SOFTWARE, INC. Agreement (Filed With SEC on September 21, 2009)

FIRST AMENDMENT TO MERGER AGREEMENT (Filed With SEC on August 26, 2009)

MERGER AGREEMENT BY AND AMONG QUIKBYTE SOFTWARE, INC., SORRENTO THERAPEUTICS, INC., SORRENTO MERGER CORP., INC., STEPHEN ZANIBONI, as Stockholders Agent AND GLENN HALPRYN, as... (Filed With SEC on July 14, 2009)

AGREEMENT (Filed With SEC on March 26, 2007)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 23, 2007)

Category

Industry

Companies

Contracts

Sorrento Therapeutics, Inc. Contracts & Agreements